<SEC-DOCUMENT>0000105770-14-000058.txt : 20141007
<SEC-HEADER>0000105770-14-000058.hdr.sgml : 20141007
<ACCEPTANCE-DATETIME>20141007092316
ACCESSION NUMBER:		0000105770-14-000058
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20141006
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20141007
DATE AS OF CHANGE:		20141007

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WEST PHARMACEUTICAL SERVICES INC
		CENTRAL INDEX KEY:			0000105770
		STANDARD INDUSTRIAL CLASSIFICATION:	FABRICATED RUBBER PRODUCTS, NEC [3060]
		IRS NUMBER:				231210010
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08036
		FILM NUMBER:		141144285

	BUSINESS ADDRESS:	
		STREET 1:		101 GORDON DR
		STREET 2:		P O BOX 645
		CITY:			LIONVILLE
		STATE:			PA
		ZIP:			19341-0645
		BUSINESS PHONE:		6105942900

	MAIL ADDRESS:	
		STREET 1:		101 GORDON DRIVE
		STREET 2:		PO BOX 645
		CITY:			LIONVILLE
		STATE:			PA
		ZIP:			19341-0645

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WEST CO INC
		DATE OF NAME CHANGE:	19990405
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8koct72014.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2014 Workiva -->
		<title>Form 8K Oct 7 2014</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s9607EF429E261956E734E7126D4C2A9C"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:4px double #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Washington, D.C. 20549</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">FORM 8-K</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Date of Report (Date of Earliest Event Reported) &#8211; October 6, 2014 </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><img src="westlogo1072014.jpg" style="height:101px;width:252px;"></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">WEST PHARMACEUTICAL SERVICES, INC.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Exact name of registrant as specified in its charter)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="33.0078125%"></td><td width="3.90625%"></td><td width="27.1484375%"></td><td width="3.90625%"></td><td width="32.03125%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pennsylvania</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1-8036</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23-1210010</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(State or other jurisdiction</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">of Incorporation)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Commission File Number)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(IRS Employer</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identification No.)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">530 Herman O. West Drive, Exton, PA</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19341-0645</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Address of principal executive offices)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Zip Code)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Registrant&#8217;s telephone number, including area code: </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">610-594-2900</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Not Applicable</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Former name or address, if changed since last report)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="4.8828125%"></td><td width="95.1171875%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="4.8828125%"></td><td width="95.1171875%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="4.8828125%"></td><td width="95.1171875%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="4.8828125%"></td><td width="95.1171875%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s94E42F99ED89FBAF4F9AE7126D5B0148"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 7.01 Regulation FD Disclosure.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 7, 2014, the Company announced that its Board of Directors appointed Karen Flynn as President of the Pharmaceutical Packaging Systems business. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (Exchange Act) or otherwise subject to the liabilities of that section, nor will it be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific referencing in such filing.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;Item 9.01 Financial Statements and Exhibits.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:85.15625%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="10.321100917431195%"></td><td width="14.449541284403669%"></td><td width="75.22935779816514%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(d)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Exhibits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit 99.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Services, Inc. Press Release, dated October 7, 2014.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s988822F130B962FB5769E7126D817DB9"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURE</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="44.53125%"></td><td width="40.8203125%"></td><td width="14.6484375%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">WEST PHARMACEUTICAL SERVICES, INC.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ John R. Gailey III</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">John R. Gailey III</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Vice President and General Counsel</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">October 7, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="sFA50FC641AEB683782C1E7126D9FC9D3"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">EXHIBIT INDEX</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="12.00787401574803%"></td><td width="87.99212598425197%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Exhibit No.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Description</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Services, Inc. Press Release, dated October 7, 2014.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exh991pressreleaseoct72014.htm
<DESCRIPTION>EXHIBIT 99.1 PRESS RELEASE
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2014 Workiva -->
		<title>Exh 99.1 Press Release Oct 7 2014</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s0D5FD1E523DFF4CCB8F3E7126B974E54"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 99.1</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:6px;"><img src="exh991logo1072014.jpg" style="height:48px;width:276px;"></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:88.88888888888889%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="44.21296296296296%"></td><td width="55.78703703703704%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Media Contact:</font></div><div style="font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Emily Denney</font></div><div style="font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">West Global Communications</font></div><div style="font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">+ 1-610-594-3035</font></div><div style="font-size:11pt;"><font style="font-family:inherit;font-size:11pt;color:#0000ff;text-decoration:underline;">Emily.Denney@westpharma.com</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">West Names New President of Pharmaceutical Packaging Systems</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Exton, Pennsylvania - October 7, 2014 - </font><font style="font-family:inherit;font-size:11pt;color:#0000ff;text-decoration:underline;">West Pharmaceutical Services, Inc.</font><font style="font-family:inherit;font-size:11pt;">&#32;(NYSE: WST) has appointed Karen Flynn President of the company's Pharmaceutical Packaging Systems business. Pharmaceutical Packaging Systems is a global business unit within West, and is the company's largest, generating annual sales revenue of nearly $1 billion.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;Karen has a strong track record of growing revenue, while maintaining high team engagement and motivation, and has been incredibly successful in the management of our Americas business,&#8221; said Donald E. Morel, Jr., Chairman and Chief Executive Officer, West. &#8220;As West enters a very exciting period of anticipated growth, the Board and I are confident in Karen&#8217;s ability to serve as one of our company&#8217;s key business leaders.&#8221;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Karen Flynn brings more than 28 years of experience to this role. Most recently, she held the position of President, Americas Region, Pharmaceutical Packaging Systems, where she was responsible for the Americas regional business segment, including both the manufacturing and commercial aspects of the business. From 2000 to 2008, Flynn was a part of Catalent (formerly known as a division of Cardinal Health), where she worked in Sales Management, finishing her career there as Vice President, Global Accounts. Prior to Catalent, Flynn spent 15 years at West, in roles spanning Quality, R&amp;D, Technical Services and Sales. In 2008, she rejoined West as Vice President, Sales, Americas.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Flynn holds a Bachelor of Science in Pre-Professional Studies (Pre-Med) from The University of Notre Dame, a Master of Science in Business Administration from Boston University, and a Master of Science in Engineering from The University of Pennsylvania. She is a member of the Healthcare Businesswomen&#8217;s Association, the Forum of Executive Women, and serves on the Downingtown STEM Academy Advisory Board.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">About West </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">West works side-by-side with its healthcare partners from concept to the patient, designing and manufacturing packaging, diagnostic and delivery systems that promote the efficiency, reliability and safety of their products. Every day, West is leading the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched and growing knowledge base of relevant pharmaceutical product testing, development and packaging. Based in Exton, Pa., West supports its customers from sales, manufacturing, customer support and research and development locations in North and South America, Europe, Asia and Australia. Established in 1923, West had 2013 sales totaling $1.4 billion.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">###</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">West and the diamond logo and By your side for a healthier world&#8482; are registered trademarks or trademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.</font></div><br><div></div><hr style="page-break-after:always"><a name="s0D5FD1E523DFF4CCB8F3E7126B974E54"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Forward-Looking Statements</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">This press release contains forward-looking statements within the meaning of the federal securities laws which are based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts. In some cases, you can identify forward-looking statements by the use of forward-looking terminology such as &#8220;may,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; or &#8220;potential&#8221; or the negative of these words and phrases or similar words or phrases, which are predictions of or indicate future events or trends and which do not relate solely to historical matters. Examples of these forward-looking statements include (but are not limited to) West&#8217;s statements with respect to planned expansions and job creation. While forward-looking statements reflect West&#8217;s good faith beliefs, assumptions and expectations, they are not guarantees of future performance. Furthermore, except as required by law, West disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions, new information or other changes. Known material risks, uncertainties and other factors that can affect future results are discussed or incorporated by reference in periodic reports under the Securities Exchange Act of 1934, as amended, filed by West from time to time with the Securities and Exchange Commission.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">&#32;2</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>exh991logo1072014.jpg
<TEXT>
begin 644 exh991logo1072014.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0`Z17AI9@``34T`*@````@``U$0``$`
M```!`0```%$1``0````!`````%$2``0````!``````````#_VP!#``(!`0(!
M`0("`@("`@("`P4#`P,#`P8$!`,%!P8'!P<&!P<("0L)"`@*"`<'"@T*"@L,
M#`P,!PD.#PT,#@L,#`S_VP!#`0("`@,#`P8#`P8,"`<(#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"`!0
M`<T#`2(``A$!`Q$!_\0`'P```04!`0$!`0$```````````$"`P0%!@<("0H+
M_\0`M1```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$(
M(T*QP152T?`D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%56
M5UA96F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBI
MJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W
M^/GZ_\0`'P$``P$!`0$!`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"
M!`0#!`<%!`0``0)W``$"`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`5
M8G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F
M9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:W
MN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!
M``(1`Q$`/P#]_**^0OVL_P#@M?\`"#]C+XY:E\/O%MAXXGUW2K>WN9GTS2%N
M+;;-&)$`<R+D[2,C'%>9:C_P<N_L]Z=8S3G2/BE*(D+[(_#REWP/N@>=R3T`
M]:[J>48VI!5(4FT]4['-+&4(MQE)71^A5%8_C_QUIGPQ\#ZSXDUJY2RT;P_8
M3ZGJ%RY^6WMX8VDD<^RHK'\*^$(/^#E;]GR>&-_[)^**;U#;7\/*&7(S@CSN
M#6&%P&(Q";H0<K;V+JXBG3M[1VN?H/17SK^PC_P4Y^'?_!1#4_%MKX#L_%-L
M_@N*RFU`ZQIZV@87;7(B\O#MN.;67/3'R^M1?MS_`/!4CX9?\$]]<\,:;XZ3
MQ%=7_BN"ZN;2#1K);QX8H&B1GE!=2@9I@%/.XH_]TTE@<0ZWU90?/VZ[7_+4
M/K%/V?M>;W>Y]'T5^?$O_!RO^SS#$\CZ;\342-2S,V@(`H'))_?=*^X_@]\3
M+;XS_"OP[XMLK#5-,L?$NG0:G;6NI0""[ABF0.@ECR=C[6!*DY&<'FGB<!B,
M.DZ\'&_<*6(IU':#N=)1117(;!1110`4444`%%%</^T'^T=X+_97^',OBWQ[
MKMMX=\.P7$-H]Y.CNHEE<)&F$!8EF('2JC&4I*,5=L3:2NSN**^5O^'V/[,'
M_15M)_\``.Z_^-5[%^S;^UI\/_VN_#.H:S\._$,/B72]+N_L-S<PP2Q)'-L5
M]G[Q5R=K*>/45O4P6(IQYZD&EW:9G"O3D[1DF_4]'HHHKF-0KQ3]NS]LFQ_8
MM^#,OB$Z#K7B_P`0WS-:Z%X?TFTFN+K5;K;NP?*1S'"H^9Y2N%&`,LRJ=?\`
M:[_:X\+?L=_":Y\2^([VP6YE+6VDZ;/J$-E)K-WL++;QO,P1<@$LQ.%4$G/0
M_A5\<XOC#^VG\<M5\<>(_BE\+=/U;52(X+6#XF65A9Z5:J28K2$"8?NTW'YF
M^9V+,W)KW,FRE8J?M*SY8+OU\E^K.'&XMTERTU>3_#S/JK_@D=^V!\=M+_;L
MUQOC%X9^)!T;XW,JM?7_`(8U&RTS2-2@5OLWDB2/9#;M%NM\!NJVY9F(+']?
M0^%&03QZ5_-'XT_8O\;^!K&'6+CXH?"II(YT:"YL?B?97EQ;SJ=\;*JRD[@5
MW`\C*\^_ZU^$?$?B/_@I+^S;\,_&-G_8/B6_T9X[#Q3I-AJ\7V6+5;>1#,=_
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M``G_`&_;;4%\`:Q=-JNDQ)<7FDZE;&TOH87.U9@A)#Q[N-Z%@"0"1D9[:F6X
MJ%+V\J;4>]M-3".)I2G[-25^Q[]1117$;A1110`4444`%%%%`!112,V,>YQ0
M`M%?-W_!-C]O76OV^OAWK^O:W\*/%WPEGT6]ALTL-?299;P/`DID3S8(254L
M4.`1E3SVK=_X*!?\%`?!O_!.#X,Z?XY\<:?XBU+2-1U4:/'%HMM'<7"S&UN;
MG<5=T&S9:R#.<Y*\<Y'2\'65;ZORWGM96?Y:&7MH<GM+Z'NE%4O#>NQ>*/#U
MCJ4"R)!J%O'<QAQA@KJ&&1ZX/-7:YVK.S-0HHHI`%%%%`!1110`4444`%%%%
M`!1110!_.W_P6WU)M6_X*@?$S><_9C80#Z+90X_G7A?[+O@D_$K]J?X6^'U4
M;=6\8Z-"X(R"@OH9'!'H41@?K7JO_!7'5SK7_!2_XP2G_ECK"6W_`'[MX5_I
M3_\`@D#X1'C/_@I?\(X-J[;+5)-18,.#Y-M-(/U`K]?HS]EEBGVII_\`DI\9
M.//BG'O+]3]4O^#A?]H>+X1?L$W/A>"94U;XFZE%H<2!L.;9/](N6'MLC"'_
M`*Z@=Z_!Y4!49%?=W_!P[^T-_P`+=_;GL_"-M,\FE_"[1UL/+SE1?796XNG'
M_;-+-.>\3>M?#5YI=SID%C)<0M%'J-L+NV)/^MB+N@<>VZ-Q_P`!KEX;PGU?
M`QYMY>]]^WX6-,TK>TQ#MLM/Z^9^L7_!K;X6:'0_CIXB.?+N]0T;1@>VZVM[
MFX/XXOU_2OD[_@N3\>Q\=/\`@HYXLM8)?-T[P%!!X8ML/N4/$OG7!';_`%TS
M*?=,'IQ]E_\`!OAXRT_X$?\`!-[XS>/]7/EZ7I'B?4=;NCD+F*TTFS#`$]\1
M8%?D'K?B:_\`&FOZAKNK,TNKZ]>SZG?NQ^9[BXE::5C[EW8FN;+Z'M,VQ&(E
M]FT5ZV7Z+\3;$U.7!TZ7?4],_8;_`&;#^UY^UYX"^';PO+INNZDLFK[?X=/@
M!FN<^@:-"GUD%?T[6L:PVZ(B+&B#:JJ,*H'0`>F*_&+_`((*:)X:_9H^$7Q@
M_:9^(-S'I/AO1(U\,Z9<R(6DD"[)KHQ+CYVDE>U@15.XO%(,8()\B_;!_P""
MZWQK_:7UV>'PAJ=W\)O"`<BVL-(F0ZI.G(#7-WC(<@Y*0[54\;GQO/!G&#Q&
M:8UTJ.D*>C;VN]7\]E\M3HP5:GA*'/4^*6MO(_?LRD-C:V/6G*VX9Y'UK^4O
M5_CAXK\1ZYC4O'?BR_U%OWA%QXBNI)B/[V#+G'O7H_P*_P""A7QO_9JUZ"_\
M)_$OQ2L<#[FT_5;V35--N1W22"9F&#CDH4;T85SSX+K*/N5$WZ6_'4UCG<&_
M>B[>I_3=17BO[$G[9FC_`+7_`.R1H'Q2\F#P_!>6TS:O;S7*F+29[=F2Y5I3
M@>6I1F#L!\A4D#D5^57[??\`P<`^/?C+XIO]!^"M[)X&\%V<SP1:_'&DFKZZ
MH/\`KD\Q2MK"V,JH!D888LF=@^?P638G$UI4(*SCNWLCT:^-I4H*I)[[>9^W
MID(8C:<#O2H^X="/J*_E1\9_M%>-?%>KK-XA^(OC'4;ZY/R-?^)+IY)3Z*&D
MY_`5TOPQ_;#^+_P8U%+OPG\4?'NBR(0=BZS-<0MCLT,Q>)A[%3UKZ"7!=51N
MJJOZ.W]?(\U9W&_P:>I_457Y:?\`!T#\4CI_PB^$_@:)P&US7[K7[@!B"8K*
MV\E5(Z$&2^1N>\0QT-:?PO\`^"R6N?'#_@DC\9O&>H&W\/?%/X=68T26YL&6
M)+NYO$2.ROX$.=A9G?*<XDMY-ORXQ^2GQ>^/?CS]H76+&_\`'WC'7_&5]I<#
M6UI<:K<":2WB9@S(I`&`6`)^E+(,BK1Q?MJUDJ;LUW=M+?>F5F./@Z/)#[2_
M4Y1U&..">F*_?W_@@-\*S\-_^":OA.^E7;<>,[R]\0,"FT^7+.T</US%%&P/
MHPK\`I$WKT&:_2G_`(-]OC7\5OB_^UPGA?5/'OBV_P#AYX`\'3W"Z-).K:;;
MDRV]K96Y0`;1M:X=.3_QZD>X][B?#SJX%\K247=WZVTM^)YN4U(PKV:U>A^T
MM>9_M:_M:^"_V*_@S?>./'6H/9Z3;.MO!!`HDN]2N7#%+:WC)'F2L%8@9``5
MF)"J2+_[2O[2?A']DSX-:SXZ\;:D--T+1XMS;0&GNY6XCMX4R/,F=OE51U/7
M`!(_`W]L?_@I7IO[=/Q6C\3?$+X;ZI?6>E+);Z'I,'CJ6RMM(MW(+85;1P9I
M`D?FR`_,4`&%4`?#Y/D]3&SYG%\BW:M]RNU_P#W\;C8T%:_O/;^D1?M4_'SP
MS^WW\<KCQO\`$;XSZSHLBHUKI6F6GPXN+ZUT&S+!A;PG^T$+$E5,DF%,C*"0
M`$5<+P]\`?V;[]U&H?M+>*H`>I3X2W$./Q-[+6+IW[27[.&B1H-3_9^U*Y9.
M&:3XQW$(_P"^?L`_G78>#_VU/V-+"91J_P"S3K%R@QGR/BBUXWY.8/YU^AJG
M5I04*4*D8K9+V5CYN4H3DY3E%M_XSJ_"G[)_[%UU(K:C^U1XY4_Q"/P9]D'X
M;K>0C\S7L7_!&3]HWP%^QS^VAJGP\TGXH:EXU\+_`!*N5TF*>7PA_9%D^HQ,
M1:7D4S7LS;)8S)$5,:EB\)^785;C/"7[;7[`.I/'Y'[)?Q&N).XAN8-04?@-
M38G\J\S_`&V?BS^S[KWBO0]4^&?P"\=^!+2ZL`-^HWUWX8>&ZAE)6>U6-94E
M90T9,JN"K*F1T)\^I2J8E2PU95+27VO9V36STLSH4H4FJL''3MS']%B_='TI
M:\!_X)J?MIVG[>'[*FA^-MD%IKL);3-?LHGW"SOX<"0#@$*ZE)%X'RR"O?J_
M-JU&=*HZ516DG9GT].:G%2CLPKR7XD?\G4_#_P#Z]+W_`-`->M5Y+\2/^3J?
MA_\`]>E[_P"@&M,+_$?^&7Y,\[-_X,?\=/\`]+B>L0?ZI:=38/\`5+3JYSU#
M\0?VB/VJ=%_8M_X+Z>.OB%X@TC5M=TK2X6M9;+38XWN)#/I<,:D"1E7:#R<G
MI5C_`()4Z!J/[7'[9W[0OQ?^&E]X?^&>JW?A;5H/#7ANPO(9+VVN;]K8PR^4
MRB,VRR6@:1L!//F0#`3YCXP?M=^"?V,/^#AKQKX[\;ZC+;:'I,+VUPMHHGN0
M\VEPI&!'N!(S^5;'_!,?Q1'^VW_P7`\3_&SX:^&;S1_AK9I>S7UT8UBB'FV2
M6RI(8LQ?:+B<+<&$,2%C+O\`,.?T2NG'!NHH\O[J/O/9VM[MMKON?-TW>MRW
MO[[TZ^IT'PX_X+#>.M5_X(?>+OB#?>+7;XI:=XFB\-V6KM:Q++_I)ANHI/+V
M",LMH\O&WI&<\U^D7["<OC&\_8W^'%Y\0M7GUWQIJNAV^I:Q=3PI%(9KA?/,
M15%51Y8D$?`Z1\Y/-?BO^TS^S3J=K_P5"\3?LY6H%KX0^)7Q4T_Q68$4J$CG
M2XE8K_LK#=W0^L:^F*_?^T@C@MUCC1(XD`5$4855`P`!V&*\#/J="G3A[&*7
MM&Y^B:5EZ;Z'HY?*I*3YV_=]WYK=_D?FS^R%^WY\0OA5^UE^UC\//BWXGN_%
M-K\+-+O?%'AV:[MX+>2*PM'ED*8C52Y>"XL3WP4;^]7SM;_\%:_CU\*O^"8^
ME>,]4\5G7/B%\5_&=SH^B7EWI\`30]-L[8&YEA555'D:Y:.)?,!"B1FYV8,_
M_!P]X1U']G?]KR#QQHD0CM?B_P"!;SP]J("X^U/`\23+Q_$8GM,>Z9YQ5C_@
ML'^R!J'[-_\`P2R_9B%M:22Z?\,W^S>))$!_T>[U"W6YFNG)XCC>\BD3)(`>
MYB'`/'KX;#X2?L:DH1_>N.EE]F+O]\K7[G'4J5E[2*;]Q/\`%JWW*YW]K^TA
M^U%_P3;_`&W/A'X.^,GQ#TCXG^&?BO<);30PP`FR#W$5N[1.8XW62*2>$CJC
MHS#:IY7U'_@G/^V3\3?C1_P5M_:'^'?B?Q5<:MX+\'/J@T;3'MH42Q$.J1P1
MX94#MB-BOS$]?6OG+]L3]KWP;_P5%_X*7?LN6/P>EU37IO#UZ+G4?.L7@-M&
M;VSN9692-P6&*U<R/C8"Z`,2:B_9-_:G\'?L2?\`!:[]J#4OB#>7FG2:M>ZG
M8:786MG)=WVK7=QJ-O<VUK!#&"SRSQ.C1KP&SU%14P2J8=N=)*JZ;;2C9WY[
M)V6VG8J%=QJJT_<YM[_W>_J5_@+_`,%.OCOXN_X)-?&OXA:C\0KZY\9^%_&F
M@:9I>IFQM0]I;7`T_P`Z,((]A#>=)RRDC=P>E?9W_!*36/VD_C"^C?%#XL>*
M-`U#X>>+O`NGG0-)L6`N8[D>7F^N5$2CSKB,-*VURJF78%4#%?EG^S/JEI!_
MP0Q_:-<W=F8H?B+X81Y1,A0'&EC!;.*_;#_@EC+'<_\`!-SX$O&Z2(W@31RK
M*P96'V2/D$5AGE.G0HU%3A%7FU>RT7+%Z=OZ[LTP4I3G#GD_A3W\V>"_\%UO
MVY/'_P"R-X/^&>A>`=8L?"%S\0]5GM+[Q-=0B9=(@A$.0`58+GS_`#&?:S".
MW?:I)RNI_P`$ZF_:G\%_':^\/?$KQ%X9^,'P=U#2$U'2/']E<0*TD[[3&D(0
M[I8V'F!PP.TB-ED*LRT__@M;^T9X.^"OPY\%Z/\`%CX12?$+X3>+M:2UUC6Q
MJ/V;_A%)U(\J:-50R&X*-,8RLD6=KIORP5OD3_@D7XRT;X?_`/!6C5/A_P#L
M\^,_$?C#X%ZAHL^JZM9Z@KB#3CY:E9B&48D6X,<:R;$:19I%8/LWCFPV&Y\K
M;C!*R;YFDT[/I).\9+9)Z,TJU>7%).3Z:)[?+JO/H;7[#/\`P53^,6H?\$F?
MCE\5?%/B7_A*_&?AB[T^QT*YOK.%8[.2ZM[9`Y2-5#A9)S)ANI`!XXKY[_X*
M(7/Q]\<_\$A/`/Q#^*GQ&T_QOX2^(NNC5=,TZYTP0:MH<YTW5?L[BXC(CE@G
MMO,=HVC5HV,(4D!\Q_L!Z3+XX_X((_M*C22FHMIFIZ-J,ZV["4I#;P6,TK';
MGA8T=CZ!2>U5/VY/VV/A_P#&/_@A3\%_AIHFL"Y\8?#5[7_A([41/Y.E0V^F
MZE812RSX\I?M+R1-"NXLZLV!E'"_14<-&GC&Z%-?Q4G[JT7*K>FO:W8\R=24
MJ-IR?P7WW=_Q/L7]N?\`;M^*$G[2WPP_9^^&WCWPW\(K*?PQ9:AK7BS5C$B1
M,]H\H4R2_*D:QQ8"KAI))5&Y0.>J_P""3_[>?Q.\0_ML>//V>_B5XP\._%,>
M'='EUK1O&6D/$T=W'"]D'3?$-DB.E]$1GYHY(94+.""/FC_@HKX)\!>"O^"G
MOPGU[X[:=<O\&O&W@ZPADN8_-5)GAL98L!XR&+13M;NRH2VQPV"*]K_X(Z:_
M\"_'G[?_`(_7X$?!J\T?PSX+T&YT\?$"3Q3>727JSSV3"U-A+%MA:9HI)%)E
M+A+0,5'FX'DXC#T(Y?=4[KDO>RLI7WYKWOTY==.AV4JDWB.7FL[VM=[6[;6\
MS]4%.Y0?6EI%X49I:^*/<"BBB@`HHHH`****`"BBB@`HHHH`_F=_X*4:F-8_
MX*'_`!JG!R!XMO(O^^"J?^RUZS_P0OU72O!/[<M_XQUR>.UT3X?>!M;\3:A,
MREC%;PBWBD95'+,/M(P!R<\5X+^VMJ0U7]MCXS7(Y$GCC6<'.?NWLJ_TJ7X+
M>/XOA=^SM\9KX!AK/C.#1O`FELIP5M[B>YU#4V_W!%IME&?]JYB!QN&?V"K1
MY\`J*ZQC'[[)_<CXN%3EQ+GV;?YLXKQAXO\`$W[2OQ<U'7KJVW^,?B-K;70M
M$;?MO;Z<".W4_P`05Y$C'J%'K7JO_!2+PKIGPU_;1\3^"=&*G2OAW8Z3X3MR
M%V[_`+'IELCN1_>=R[M_M.3WKU#_`((4?L^)\>_^"B'AN]NHTETWX=VDOB>X
M5\$&5,0VPP>_FRAQ_P!<L]J\=_X*%>(3XM_X*!?&W4BNSS_&FH0X]!`XMA^D
M(/XTX5D\=]7CM"%_O:M]R6GJ$H6P_M'O)_E?]6?1MK\48?@]_P`&\J:#'(BZ
MA\6_'UU8^63\SP0S++,P]MMJBGI]\?C\'W)E$"B"WN+RY<A8;>!=TUS(3A(T
M'=V8A0.Y(KUSX_\`Q+.O?`WX%>"X'/V+P5X;O]0E0#&Z^U/4))96/KBWM[0+
MG[NZ3^^:]8_X(H_LVC]I;_@H1X5%S$DFC^`HV\6:@'7*L8'1+9/J;B2-A[1.
M>U12E'"8>KB9]Y2?WV7WI+[QS3K584H]DO\`/\SH_P#@K'JEQ^SM\-_@U^R]
M936QL_AEH$.O>*9+:4M'J&NWF]B,%1\L*F5U;^+[6O"F/YOB#7M0DTKP]=W4
M-O+=2V\#RQV\8+23L%)6-0.K,<*!W)%>U?\`!07XMM\<?VZOBWXDW/)!-XIO
MM/MBQR1#9RM:)^'[@D?6O._A_P##S7OBYXPL?#OAC1K_`%_7]39DM-/LTWSW
M#*I8A1D=%4G\*Z,OI^QPL>=ZVYF_-ZMLSQ,N>J^7;9>BT1^RO_!1']E?X<?L
M8?\`!%+7/"4.A>&KG6-*LM.LEU)+.,75WJ\ES"LEYYF/,$C-YAR3D+\OW>*_
M$Y<A@<<=SZ5[9#_P2X_:#@?='\#?'Z,.XT\?_%5-_P`.R?VBPF/^%)_$(8Y_
MY!X_^*KARN-#"4Y0G7C-R;;=TM[>;-\6ZM:2DJ;5E:UG_D?1.C_%?4/@W_P;
MJ3Z7;O)#)\4/']YH0/0M9L[27`'JKK:NA]1(0:^!BI*>^:_;'Q3_`,$H->^,
M_P#P15^''PM@2+0?B+X8AA\3V]OJ!,:#4I/.DFLYB,^7N6YDC+#(5PI((!K\
M;/B[\)O%7[/?Q`D\*^.?#^J^$_$,6YOL.I0^4\Z*<&2%ONS1\CYXRR\]:G(\
M9AZTJRIM<SFWYM='Z6*Q]&I%0YEIRI'Z3_\`!&S]K;]E[PC^SC-\,_B)IWA;
MPQXTUFXGCU/4_$]A%)8^(A*Q$6;MU*QHB;4\J5E`()4DM5'1?^#87Q+J6DVM
MQ:?';PI=VL\8>&:'PG-)'*A&0RL+X@C'?)K\R&570DKD$8(/>O4?V4OVV/B=
M^Q!XL@U;X<^(KJQM87#W&@7,SOHNI@<^7-!RJ[NGF1A9%SP>Q5?*L33G.M@*
MO+*>K4DFF_)O8*6+I2C&&(A=+JM/^'/UX_8^_P"""GAOX._`_P"(/@?XF^)C
MX_T[QYJVF:A(-,MYM&6!+!9&@0XFD9CYTTKDA@,!!C@D_C)\>[?PU9?'[QW;
M>"X#;^#K+Q!?6>AQF=IS]CAG>&)][?,V]4WY//SX[5_1EKW[8&EWW_!/J]^-
MNGQRV>GW'@E_%%M!.X,ENQM#*L+LO&]9"$)&1D'&:_F:TN-XK&)969Y0H\QC
MU9OXB?<G)KS^%ZV)KSK5L1)O5*W2_71:7LDCHS:%*G&$*2_X;^FSUO\`88^!
M5K^TU^V7\-_`FHQ3S:1XAUE(]22%V1S:1H\LP##E<I&1N'3-?N_\(?V3O@=_
MP2;\`>.O&F@6=]X<TK4;>WDUJYGNKC49IEMS+Y$42'<Y8M.X"(,LSBOS%_X-
MR/A4?&_[>VK>))$#6W@7PO/,&*D[;B\E2"+GL?*2YZ]>:_83]LC]G./]J[]F
M_P`5^!3?3Z3=ZU9-_9VHPRO$^G7B?/;SAD(;"R!20""5R.]>=Q/C7+&1PTI-
M0LN9+UOMZ6.G*J"5%U4DY:V^X_$/]M3]O7XT_MS?%Y=8;X7ZBOA32)G/AO0-
M2\$-J_\`9J,-K3.TD#`W$BXWE?E4'8N1EFQ_!'C?]H:P@5M+_9NT'4(UP!(_
MP'AES_P/[(/YURNB^!OV@]!UZ[TB7XEW/AO6M)N7LKZQNOC#;6,UC<1L5DB8
M/?*058$=!TS7JGA#X+_M?Z]*ATSX\,S/]W_B^-O<_H+N2OH7'#TJ:A#V:BMK
ML\].K.3E+FOZ'=?#CX^?MEZ0ZG1OV6?"[,N-I/PG2P(_'S80*]M\&?MK?\%!
M-*18X/V7O!\8Z9_LDV?_`*#J6/TK@O`7[('_``4,U5%&G?'B%$.,>?XXBOOU
M^RRG]:]1\*_L4_\`!1JQ8-)^T1X-BP.EW=&Z_0:97B8AX9O7V/\`Y/\`H=])
M5?[_`.'ZG<^%/VN?V_-093>_LQ_#UU/)W>*!8\?C-+C\J^>?^"K_`,?OVFO%
MEE\/X/%?[.WA3P_-#'J+H]G:P?$/S0QM0<E]/_T`@J.`[&;/./*%?2'A?]F3
M_@H!9E1>_M%_"E0#R6\+&\S_`.08J^(/^"F7BO\`:&M/C==:;XC_`&A/!^K1
M>$+%+2ZN=`\7VG@VWCDP99EGL!J!<21[@#)+M)`&%4#G++J="6*CR*EIVY^U
MNNA6)E45%I\^O?E_34Z+_@C#^V+XV^!7[7L/A?QEX3F\/^#OB9LTZ5[?P<-%
M@M-37_CTG<QP1J0XW0$M_?CY`6OVX0Y05^9W_!'G_@E]XX\.:C9_%GXXZ]XG
MU'5XF$WAGPS?ZW<7D-@,<7]R&E97F8']W'C$:_.V78"/],4&U`.F!7C<05J%
M3%MT+:*S:V;78[<MA.-&T_E?<6O)?B1_R=3\/_\`KTO?_0#7K5>2_$G_`).H
M^'__`%Z7O_H!KR\+_$?^&7Y,RS?^#'_'3_\`2XGK$'^J6G4V#_5+3JYSU#G-
M<^#GA'Q-JDU]J7A7PWJ%[<8\VXN=,AEEDP,#<S*2>`!SZ57^)VG:SX>^#>O0
M>`K+2X?$=KIDXT&VEC6.T%WY;>2K*,`(7QGIP37,_'S]H&;X2ZOI6E:;I']L
MZOJ^6CB:8QJB[@J]%)9F8D`#'0G/8][X3U6YUKPOIMS?V;6%]=6L4US:%MQM
M9&0,T9/?:21^%;RA4A&-26SV_P"&.6EBJ-2M.A!^]'?1Z7\]KGP+^P3_`,$[
M?C1J_P"W)??M%_M':AX=/BVUT\V&CZ1I#))'"[Q^5YK%!L1(H3(B("[,TSLS
M#:-WZ&-A5]!FD615&!QCM09@QQ@^E5C,94Q,U.=E9622LDET2-:-&-./+'\3
M\TOBQ_P3R_:)_;Y_;=T34_C3?^$M'^#?PZ\2W=_H-GI[))=:G8BZ#P1M&I)$
MLT<4"R22,`JAPJ98U^E-SIT.HV<T%S#%/!<(T<L4B!DD5A@JP/!!!.0:E*+&
M,XQB@R[3R#@]ZK%8VI748R22BK))67G\V*E1C"[6K>]SFOA]\$_!GPE-T?"O
MA+PSX9-]C[2=)TN"R^T8SC?Y2KNQD]?6K5S\+O#-YXZM_%$WAW0I?$UI";>#
M5WL(FOX8CD&-9ROF!>3P#CDUN-G'%>;_``9^/$OQ9\6>)M-?24TX>'IQ"LBW
M9F-SF25,[=B[?]7G&3][VYQBJDE*:Z;Z_(FI7I4YPI2T<KV5NRN_P.FM?@[X
M1L=#N=,@\+>'(=,O)%FN+2/385@G=<;7=`NUF&U<$C(P/2MO2M)M="TV"SL;
M:WL[.UC6*&"",1Q0HHP%51@*`.@'%3"4$'/&*1I@O8\\5FY-[FZ2Z%?6]"L?
M$VDW-AJ5G:ZA87D9AN+:YB66&=#P5=&!#`^A&*S?`7PM\,_"K27L/"_AW0O#
M=C))YKVVE6$5G"[_`-XI&J@GWQ6XS[3C!)ZUC>.?$[>$O".IZJL'V@Z9;27'
ME%]@DVJ3MW8.,^N#3BY/W5U)G*,4YRZ#_"W@#0O`UG);:)HNDZ/;S,&DBL;2
M.W20@;02$`!X`'/;BLC3O@!X#T?PU/HUIX)\(VNCW-R;R:QAT>W2VEG(P96C
M";2^"1N(S[URV@?M4Z>/A##XNUO3Y].MIKYK!8+:0W;!@&(.2J=0I[5/\4_V
MAC\/-0\*1VVDKJ,/BG:5DDNC;M;JS1@';L;<<29QD=,5NL/7YN6SOKUZK_(X
M'FF$5/VO,K63VZ2=EIOJ=QXM^'F@>/O#;Z-KNAZ1K6CR;=UC?V<=S;-M^[F-
MP5X[<<5)X.\#Z+\.]`ATKP_I&EZ%I=MGRK/3[6.UMXLG)VQH`HR?05H^:%(&
M#]>U<3\-_$7C'5O'7B"VU_2+6PT6UE==+N(SEKI!,ZJ6^8\F,(W0?>_"L8J4
MHO71>9V5*L8SBFG=Z;?/5]#N:*89AV!(I!<`KG!QUK.YL244Q9=SXP:#,!V.
M/6F`^BHVN`N,@\TOGC.,$'TH`?13'G"'&#2-*&&.<F@"2BO-OA;\>)?B1\2/
M%&A/I4=BOAR>6%;A;LRFY"3O%DIL79G9GJ>N/>M[XO?$%_ACX`U#7DLQ?&Q"
M,+=IC")-SJOWMK8^]GH>E:RH34U3:U=OQV.2&.H2H2Q$9>[&]W9_9O?STL=7
M17F=K\:M0O\`PSX,U2+2-/$?BU_+,<VJ/&UJWE2387$+>8-D3_W3G`Q@DC@=
M?_;P_L32],G'AB&22]A\R9)-8\I8&(5U56\D[PT4D4@;`XE`QQ6D,'6F[17X
MHYJV<X.E%2J3LGY/R?;S1_/'\?=0.L?M$?$J[SO^T^,M<D##^('4KG!_+%<N
M%PF,MM!W;<\9XR<>O`_(>E=OXA^"7Q#UGQ1J^H'X=_$(G4=0N;PG_A&;[_EK
M,\A_Y9?[54F_9U^)^IR):Z=\-?'TVHW;I;6D4GAV\C22>1@D2LS1A54NR@L2
M``220`37[+"K3C!)R6B[GS$HS;O9G[!?\&UO[/0^'W[*GBCXB7<174/B3K(B
MMV/:PL-\,0'UGDNVS_MCT%?CG\7O$C>,?C1XTUAI/-;5O$.I7F_^_P"9=RN#
M^(-?TT?!3X46'[*7[,OA[PCI2-<6?@70([./RXSNNVAA^>3:,G=(X9L#NU?S
M,Z+\!_B)<Z7;3/\`#KXAB2>,2MGPS?`Y89.?W77FOE>'L6L1BL3B9/1M6]-;
M?@D>MF5%TZ-*DEM?]#G=N#DEF(&!DYP!T'TK]O/^#<7]FD?"W]D35_B%=*PU
M3XJ:D)D)Q\MA9&6&W7\9&N7_`.VE?D+X!_9$^)GQ8^(.@^%;'P1XXTR\\2:A
M!ID5Y=>'[N&&S,KA#,[M&%58P2Y)(&%-?TU_##X;Z3\(/AGX>\*:!;"TT3PQ
MIMOI6GP#D16\$2Q1K[X512XNQ\50CAX._,[OT7^;_(>38=NHZLEM^O\`P/S/
MY/\`P;<2ZAX3TN>=WEFN+2*:61CDR.Z!F8GU)))^M?>?_!N_X0LO$_\`P4BM
M[J\G$<OA[PEJFIV<>1F>;S;2VV@'KB.ZE;CGY!VS6!_P4_\`^"47CG]D#XT>
M)-=\,^&-5U[X5:M>SZIIU[I-F]RNAQS2-(UG/'&"T:Q,Q5&QL,>SD$%1\31?
M$?08;CS8O$6E03V[$AX]3CCDB;H>0X*GDCMUKZ"3IYCA)1H2TFK::VOW7X'G
M)3PU9.I'X6?JQ_P5T_X*_P#Q.^%?[:>J>#OA)XUCTCP_X4T^WL-0$%K;7:W&
MI%I)9SN=&(**\,14'`:)NYP/*OV0?^"GG[57[3_[4O@'P#:_$NX9/$6MVT5Z
M4T:S)CLD<2W3<1@C]PD@SG@D&OC;X"?`SQA^T[JRZ?\`#/PKK7C63?M+Z-;&
M>UA)/\<X_<I[[G%?MY_P1Z_X)$#]A:SNO''CB:PU;XH:Y:_9%6U<RVGART8A
MGMXG./,ED*H99=H'R!$^4,TGA9C#+\NP?LW&,JEK+17;[O>W?7T._#2Q.)K\
MUVHW[NWH?/'[;_\`P7S^+O[/?[7?Q`\">%O#GPUNM!\):H=.MI=3TZ^ENY"L
M:%R[1WD:'YRV,(.`.O6E_8I_X*M>*O\`@IM^TQX?^#OQD\#?!G4O!/B&*[GF
M@?1;EI6GAMI'B$1GNI463.<$)NQNP0>:\N_X+B_\$X?'O@7]J7Q+\5O#/AW5
M?$W@CQFRZC>S:5:/<RZ+=K&J3+/&@+B-]HD60`CYF!P5!;\WY?'N@+<LC:WI
M,4\#_,IOXXY874]QN#*P/T(K;`91@,5@XRH17,X_$KW4K;VOO<BOC,12KN-1
MZ7V[H^VO^"V?[(_PM_8W_:=\/Z!\,+BYM_[9TB74=<T*2Y-S%H,GFQK;>6[$
MN!.AG8QL24$",.)17QU=&2.W806]Q>7#86&V@7?-<R$X2-!W=F(51W)%7/AE
MX?U+XZ>)6T[P5I^I^-]9N),O#HD+ZI.SGO(8MV"<=7(Z5^L?_!(K_@AYX@\`
M_$K2/BO\:K2WL+G0V6[\/^%0XEFAN@<I=WC*2@,?5(5+?-AG8%0E=];&T\MP
MJCB*G-)+KO)^GX7.>%">*K-TXV3^Y'>_\%2=.NOV-O\`@AGX:^&ES-`-7NK+
M0_!]V86\Q)95"37>P\':?(EP<=",CFOQ9`Q7[F?\'#O[./C/X]?LG>&;OP;H
MFH^(Y?!_B)=2U#3["%KB[>V:VFB,J1KEGV,ZY"Y."3@X-?A5JFJ1Z!=-;ZB)
M=.N$.UHKR%[>13Z%7`(_*N+A6<981RO>3DV_P-LW359*VB22/TX_X-[/VH?A
M)^S3X?\`B3%XX\::7X:\7>,==TVRT^RO$</?6T<6R#R2JG>S7%S,FP<@A3CY
MJ_9O.]#CZ5_-O_P2<^$%W\</^"A?PGMHM.O[K2M.UM-9NYQ:2_9DCM(WN%W2
M%=@^>-,9/)Z<U_24!BOF.+*%.&,YHN[DKORZ+\CULGJ2E0LUHM%^9^-W_!?W
M]@W0O"/QUTWXQ2:\?"^@>.S'I>L.NBS:BL>J1QL8Y2(F78)H$QSU>#KEJ^&=
M-_9S^!NL1`ZE\?+.U)^\C?"[4+C'_D<`U_15^V!^S)H?[87[/'B;X>^((W^P
MZ_:[8YHW$<MI<(PDAF1BK;6615.=IXR,'-?SL:MJ'PN^&7B[5?#OBWX,?$!-
M?\.WT^F:I;Q_%2*,0W,,C1RH%_L7.`RG!W<C![U[W#F85<1AO8J4N:&FG)MT
M^)?(\_,L-&G5Y[*TN]]_E]YU'A_]AW]E3574W/[4^CZ>6`W>9\'+V,C\?M+?
MRKT;P)^P/^QA:W2FZ_;(NX&&.=,\+?V20?9IHY<5YQX;^,W[+=HR_P!J?`;X
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M.YG*EF^0`R?KNB;>>YZU\KFV;2H1EA:$Y-OXF^73^ZFOQLSU\)@U4:JU(I+H
MM?O=_P`-!50#![XI:**^1/8"O)?B1_R=3\/_`/KTO?\`T`UZU7DOQ(_Y.I^'
M_P#UZ7O_`*`:Z,+_`!'_`(9?DSR\V_@Q_P`=/_TN)ZQ!_JEIU-@_U2TZN<]0
M^6?VE_#.IR_M*:'$FMRI+JYB^P2>5SI7[S9\OS?-\P+]NN/>K.I^']:^,GQ[
ME\#ZCXHU6VLO#FF(9)K5C&UY)''`KR%<XWN\V<MNP%P/6MS]HG2KN[_::\!3
MPVEW/!$8?,EC@=D3_2#U8#`_&LWQGJNH?`+]I_5O%EUHNHZIH^M6A@CDM$W%
M2X@)&>FX&#H2,AL@\8/NTYN4(*-N;E=MM[_Y?U<^"Q5",*]6<[\CJQYM9?#R
MWUL]K_Y=C*\(>,-<T'P/\5?"MUK%]?CPW`XL[QI76:/;(T9VMN+*#M4@;C@Y
MYKK/V6?`&MZ[9Z!XPO\`Q->WEK;QW5M#ITV^0*#)(A8R%^6W9/*GC`SQ7(>$
M?"^LZ]X(^*_BNYTF\L8O$5O(;2U>-C+)ND:1MHP"P`*C..3G'2O9/V3;2:Q^
M`VC17$,UO*KW.8Y8RCC-Q(1D'GH14XR:C3ER;MJ__@.IKD]&53%4O:W<5"3C
M=OI4]WUTVOT-CXTZ1XCU_P`$7%EX8O;;3M1N&57N99#&8HN2Y5@#AN`,XX!)
MKYJU'4$^#GQ$\.'P]X[O?$.IRSI'K4?VHS6ZN9(P5]&5@SCDLPV9SSBO7_VV
MDUJ;X41Q:4ET]K)>*-1$"LS&'8V`0H)V;]N?PSQ7D'C>2U\0V_@9?#7@W6]'
MT;3KG#3RV1#7<ADMR[';DD+M^^QYR<<+2R^'[M7>COV[=>OHD/B&K>O)034X
MJ+3O+^;[*6B_O-^A]A1#:I'7!KY)^%7@.;X@>(/B;"-:U32+2SFEN)H[%@CW
MCB6Y\L.YY"+AB5'WBPY&W!^MD.<_6OG/]G#2;RQ\1?%@SV=Y`+C?Y)D@=!-^
M]N_NY'S=1T]17)@JCC2J26^GYGK9Q157$8>,E=7G??\`E?8YKP]\8/$&@?LA
MSS6U_<M?-K']G0W#2EYH8C'YFU78D@\%03T#>PK"/CBU^%5_H.K^%_&^KZ[J
M$SK_`&Q:732>2Q.TL`&&"I)9>2S`@'=6GX9^&.M^+?V1M0M+33[U;^SUS[7]
MG>%DFE00A"44@$D;L\==I[UK:3XW_P"$YO/#^B^&?AMI4&HQA(]5N-3T.-XX
ML;59PV`0!AFW-@DX&,UZUX)RY5=7=]K;+?R[6/DU[:4:7/)I\D.5VDW>[ORV
M:5]KWZ>1V'QU\!W^O^-)=0\6>-(_#/@F",K:Q6MV8IW<*.JE<,Q)8DX8@```
M9R.4^"?C2^UOX._$K2I]3N-7L-*LW:QGG9F=HV64`Y8D@,$5MI/&XBHO$&H?
MV3^U-K%YXL\-:UXD5,QZ);P6IGCQN7RBH)"E=N[G)`8DD=POP<TG4E\._&!K
MO2KVQN+VW=UMWA;ABUP2B':-^TG&5Z\>M8*%J%I._P`+6UMUMU]6=[J<^.<Z
M::NZB=^9MVB[7Z)?RI'':_IMR_[*FAWRWC+8V^LW,$MEM^6>1@624MG@J$9<
M8YWGFMWXN>%]7\/6'PV@N]=DU.[NY/.M;F6#_CS5VMO+3:6.X)UZC..U/O\`
MPCJE_P#L86\$>FWYGM-=>YFB-NXDCBPZE]F-Q&6':I/'7BJX^*%I\-+RTT75
MX$TRX%E,'MV?!C>V!?('"GG!..A]*W4[S35K*4NW;0\Z5&*I--/F=.E;?I)7
M^[3TZ;LWM)TB^^%'[7ND:5#KVMZM#JT.^\:_N#(9RT<I.0,+PR`C`&WH.*?\
M)O'.HZ%\1/C!>-=W=X-):\FMH;BX>2*(I=7&T!2<*.`,#'``K6\>Z7=R_ML>
M&;E+2[>V2W3=.L+&)?W<_5L8'4=^XK'^$W@R_P!=^(GQALC;W-I_:K7D-O+/
M"\<<A:ZN-I#$8(.0<C/!S7-*4)0YI?RJ_P#X$>K"%6GB5"E>RJ3MO_S[TW\S
MS:/Q'!J7@^[\17GC_7X_'*3%[>R6201,NX<9`P"1DC!"C`!4]^R^)/Q%U_Q?
MH/PJU"'4[BPU/5%DCDD@E=(I)1/'$)'12`PR-Q4\<D=*R?"?BH?#WP--X:NO
MAP=0\9)<LL$UYHZ7*,K/GDXW-@9``)!X.X"NG^+GAS6%O?A.MSI$-O=PR"2[
MM],M"MM9EIX6V;5R%P#SSC(8UTR<?:*ZZNVVUGVZ;;GF4(U'AY\LG>T.9)2^
M+G6K;?Q6O>W0]J^"_P`-;KX7^&KBQO=:NM?N+F\DNVN[A&5SO"C:<N_=<]>_
M05Y??>*;OX6?M=ZU)=WE_/I&IZ--=Q6LERQA1U1),JI)`.;>0#`'^M->_1?Z
ML5\[_MR^%[XR:%KFGVMY<2JL]C+]FB:1P"I=<A02`5649QCMW%>1@Y>TK.,_
MM)_YGUV<TWA\'&I03_=--+5Z;-=6]&<7\&OB]JVA^`O'\6H7U_<7<^CC4+62
M>XD8QNS>42A))4$S(1MQC%2ZEJ7B)/A]\.?#`UK5+)O%S&]NKDW$DDS)-,%A
M!8L&VB(J2FX9)IOQ]^$6IZ#=>$+/3[2]D-_H5MI5T8(6=?,1E#!R`0!DJ>?[
MM=O^TYX+O_"6L^"-?TW3;C4M.\+^7!+#;J2R+&RLF0`2%(4C=@@$#/45ZG/2
M<XN-O>N_N5E^)\PJ.*C2J0J-VI**ZZJ4U*6W9:/R*/@NRU+X`?M+:3X6AUS4
MM9T?6809([QRQ0LLA5@,X#!H^J@9#$$=ZQO@3X-U[XO>(-<#>+=4L[#1=8BN
MGMW>2X^U,)'(4DR+M0!2,<@ELD?**V/!>HW_`.T%^TSI/B>VT74M+T?180)9
M;M-N2JR`*#T+%I!P"<!23Z5K_L7:7=Z=J?C@W5I=VHEOT9#/"T8<9EY&0,CG
MM656;A3E)VY[1OMO?_(ZL'2C5Q%."O[%SG;67P\JZ[VNCG/A/KLOA?XD_&;4
M8`#<67VZ>//0,MU.1^N*YO3O!5_JW[-NM^,+CQ'K<US=S^7<6DL_FVUT@F0'
M<K9(?=\P8$8P!@@FNJ^&'@S4-;^(7QBLQ9W4#:FM]#;O+"T:3,US-MVL0`<Y
M'3UKF?#WBO4O^&==:\$#PSX@?4[:9I9Y1:E8K=/-5FW9Y+@@J%`).0>@-;)^
M^W#>\+[;6.)Q_=*-5.W+6Y=_BYG;;K8^A?V;HA)\!_"N1G%@F/;K7;?9(\?<
M7`Z<=*X[]G.VDM/@=X8BFBDAE2Q0,DB%&4\\$'D5VM>#7_B2]7^9][@%_LM.
M_P#*OR0U8]O<G\:%CQGDG\:=161V7$*`X]J;Y7^TWYT^B@+C1%@_>)^II57:
MH'I2T4`-,><\D?2J>H^&M/U>XCFN[*SNI8ON/-`DC)]"1D=:O44+38+#?*YY
M)/XTJKM&*6B@!K1Y;/2J>J^&[#7507UE:7HCY7[1"LNWZ;@<5>HH6FP>I'%;
MK#&J)\J(-JJHP%'H`*>J[1BEHH`0KDTTQ9_B;\Z?10`T1^Y/XTZBB@!&&5(]
M:_(7_@O[\#+K]GKXM:!\8?#O@WP?JVD>.)1I?B"34/#L-^T.J11`V\KY&XB:
M"-DR1@-;*"<R**_7NN!_:>^"*_M&_`;Q1X*_M;4]`FU^Q>WMM4T^=X+G3;@?
M-#.C(RME)`K$!AD`C/->AE>,^JXF-5ZK9^C_`*N<^*H^UI."WZ'\ZT?[9>O6
M]N(S\)?@QM88#/\`#6`D_B5K[1_X)2?L$ZE^WO=1_$7XF_#[X;:/\*8'=;"P
ML?"5O92^*Y02I(QREFC`AFQF5AM&%#%J_P#P3#_87_:*_:6^+.J?\+>^(GQH
M\/?#OP%JDNF:KID_C/5E'B6^MY"DEI`?/&;0,I+SCAU*JGWF9/V:M;5+.!(H
MU"1QJ$51T4`8`KZ?/,WIT4\/A4N9[R3O;T\_/IZ[>5@,&YOVE2]ELG_PX6MK
M'9P)'$B11QJ%5%&%0#@`#L`.U2445\0>Z%%%%`!7(^)/A<OB#XGZ#XF-Y+%)
MH44T2VPC!6?S`1DMG(QGM774549.+O$SJTH5%RS5U=/YIW7XC8AMC`/:G445
M)H-\H9)Y&>M(L`4\$C\:?10`WR\]S2JNT=S2T4`-*`MFCRAGJ?SIU%`#1$`I
M'8TA@!`Y/'O3Z*`&F($=32>5D\DG\:?10`WRQC'.*/+Z\G\^E.HHL`P0@-G)
M_.@PY_B;\Z?10`WRQC'.*!$`,9)&,4ZB@!OE`=V_.CRAMQDX^M.HH`0#:,4G
ME`$GD$TZB@!HB"G()&:#'^%.HHL`T1#.2230T6[N:=118!IB!/)-!B!'4_G3
,J*`$1-@I:**`/__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>westlogo1072014.jpg
<TEXT>
begin 644 westlogo1072014.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``(!`0(!`0("`@("`@("`P4#`P,#
M`P8$!`,%!P8'!P<&!P<("0L)"`@*"`<'"@T*"@L,#`P,!PD.#PT,#@L,#`S_
MVP!#`0("`@,#`P8#`P8,"`<(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"`!5`-(#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#]_**^=_VB
M_P#@JM\"_P!E#XH3^#/'GC)M%\16UM%=R6HTN[N-L<H)0[HXV7D`\9S7"M_P
M7H_99123\2'`')_XD6H?_&:]6ED>8U8*I3H3<7JFHMI_@>75SO+J4W3J5X*2
MT:<DFOE<^PJ*R_!/C+3_`(B>#=)U_29FN-+UNSAU"SE:-HS+#*@=&VL`RY5@
M<$`CO7S%XO\`^"WO[,W@7Q=JNAZC\11'J.BWDMA=I'H]]*B31.4=0ZPE6`92
M,J2#C@US8;+L5B).&'IRDUNDF[>MCHQ.8X7#Q4Z]2,4]FVE?TN?6-%?-7P+_
M`."NOP!_:2^*VD^"?!OC:35_$NN-(MG:?V3>0^:8XWE?YWB51A$8\D=*]K^-
MOQK\,_LZ_"W6?&GC#4TT?PWH$(GOKMHWD$2E@@PJ`LQ+,H``))(HKY?BJ-54
M*U.49RV333=]%9=;O0*&886M2=:C4C*,=VFFE;5W?H=517Q]_P`/YOV6O^BD
M/_X(M0_^,UZQ^RI_P4&^%'[:^J:S:?#;Q'/XAE\/Q12WY_LVYMDMQ*6$8+2Q
MJ"3L;@$G"FM\1DN84*;JUJ$XQ6[<6DOFT8T,YP%::I4:\)2>R4DW]R9[3111
M7F'I!1110`4444`%%%%`!17*?%/X[^"?@;:6=QXT\7>&O"4&H2-%:R:QJ4-D
MMRZC+*AD8;B`02!TKC/^'@7P*_Z+)\+_`/PI[+_XY713PE>I'FA!M>2;.>IC
M*%.7+4FD^S:1Z]17._#+XO>%?C3X??5O!_B30_%.EQS-;->:5?1WD"RJ`60O
M&2NX!E)&<C(KHJQG"46XR5FC:$XR2E%W3"BBJ'B?Q-8^#M"NM2U*XCM;*SC,
MDLCG@`=AZDG@`<DD`<U)1G_$_P")NC?![P+J/B/7[M;/2],B\R5\%F;LJ(HY
M9V.`%'))%?FL/^"C_C7Q'^V%HWCV\LM9LO!6G3-8#1TAD:*'3Y2%D=\##S\+
M(3V*!1QUO?M4?$?XZ?M:_$<77AGPUXPT7PMIC%-*M+2X6WDD'>>8JXS(PQ@=
M$'`YW$\!K?[.W[2XT:2]U"P^(+6<8R[2ZYD(/4CS^![]JM)=0/UTL[V+4;.*
MX@D66&=!)&ZG*NI&01[$&I<U\A_L(?$#QCXV_99U?P+JZ75OXN\+!8;8R7T?
MVB_L6<,`LBNQ5PH>'>2-N8SGG->I_LG>`/$G@B;5/[56^@L)47;'=''F3=2R
M1EF*!1E68GYR<C@"H`]IHHHH`_G>_P"#@+5!J/\`P5(\;(#D66G:5!]/]"C?
M'_C]?&4-B^J3QVL0W273K"@]68A0/S-?4_\`P6VU?^V?^"HWQ8?(/V>[L[?_
M`+XL;<5XQ^R3X+/Q'_:L^&6@!/,&L>*M,M64]U:[CW?IFOZ?R1JADU"3^S3B
M_P#R5,_E_.HNOG5:*^U4DO\`R:Q_1O\`M6_&.#]AK_@GYXB\2!EBF\&>%TL]
M.4G&Z[\I+>V7\963\,U_,1-/+=3/+/(TTTK%Y)&.6=B<EC[DDFOV6_X.?OVC
MO[%^&7@'X4V=P!/X@O'\0:G&O!%O;YC@4^S2NY^L%?C1M.W.#C.,U\UX<9>Z
M67RQ<_BJRO\`):+\;L^E\2,P]KF$<'#X:4;?-ZO\+(^TO^#??0_[8_X*A>#Y
MBNY=-TO5+H_[/^BO&#^<@K[O_P"#FOX^_P#"%?LK>$_A_:S!;OQUK/VJZ16Y
M-I9J'((]#-)!_P!\&OD7_@VH\/'5O^"@FK7NW<NE>#KV0GT+W%J@/ZG\ZYK_
M`(.$/C__`,+E_P""ANIZ);SB;3?AWIMOH404_+Y[#[1<'Z[Y50_]<O:N?&X/
MZYQ?3OM2@I/Y-V_%HZ,%C/J?"%2VCJS<5\[7_!,^'"<"OZ#_`/@W_P#V7O\`
MAGW]@;2M<OK;R==^)5P?$-R67#K;,-EHA]O)42#WF-?AM^R)^S_>?M4?M->"
M/A[9*^[Q1JL5K<2("3!;`[[B3_@,*R-^%?NQ_P`%"_\`@KG\.?\`@F?HMCX*
MTC35\4^-;:QBCL_#MG,(8-)MP@6%KF7!\I=H&U`"[`9P`0U/Q`JXC%*EE&#B
MY3F^9I=EHK]$K]7V)\/J6'POM<WQDE&$/=3?=[V[NW1=S[2)`HSQ7\]WQ5_X
M.%/VE?B'J4TFEZ_X>\&6<A^2VTG1HI#&.P\RX$K$^_'TKEO#W_!=']J7P_J"
MSGXG/J`7K#>:+821M[$"%3^1KY"'AGFKCS.4$^UW^D;'V$_$W*8SY5&;7>R_
M^2N?T=45^;G_``28_P""Z,W[87Q'M/AI\2])TO1/&6H1.VDZGIVZ.RU=D4LT
M+1L28IMH9AABK[2!M.`?NC]HW]I'P?\`LI?"/5/&_C?6(='T'2E&]V4O+<2-
M]R&)!S)*YX"CW)P`2/D,PR3&8+%+!UX>^[62UO?:UM[GV&7YW@\;A?KE"?N+
M=O2UM[]K'=YQ1D`=:_#S]IS_`(.7OB=XXURXM_A;X>T7P/HB,1!=ZG`-1U.9
M>S,"?)CSUVA7Q_>-?/\`-_P6_P#VI9KLS?\`"U[U,MNV+H^GA![8\CI7U6&\
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M6OWGA[+I8#+J6$EO%:V[O5_BS\$XBS*./S*KBH?#)Z>BT7X(_H]_X(>_"`?!
M_P#X)G?#>)HO*NO$-O-K]P"N"QNIFD0G_MEY0_"OK2OR]_X(6_\`!2/XI?M=
M_$J3X>ZOI7@[3O`WP^\)Q"-M.L9HK@-&T5O;1EFE9>5$A/RC.SC%?IUJNJVV
MAZ9<7EY<0VMK:1----,X2.)%&69B>``!DDU_/?$^$Q%#,ZJQ-N:3<M'?XG=?
M@?T-PQBZ&(RVD\-?EBE'56^%6?XD/B;Q-8>#?#]YJNJW=O8:;I\+3W-Q.X2.
M&-1DL3Z`5^9G[;W[0%]^VAXL73-,\:^`M$\!Z9-NL;2]USR9-0D'`N9UV'!_
MNH?N#GJ3BU^W+^VSX<_:OU;_`(1RQ\9ZKX?\$:?+EDBT![@ZO*IXF<B53Y8/
M*)C_`&CS@#Q?1?A?\&;L#[;\7]?M2>R^"IF'?OYQ]J\.,>K/?)]!_8O&M%2/
MBK\%;8'^_P")L$?AY8]J[C1_^"<U[JMN8_\`A=WPD\F48:.+7WE##T*\`BLS
M1O@+^SI>8%S\==<C)]?"TL7\U:NLT7]ES]E2XV_:?CCJ,N>H:W2W_P#0H#5-
M@9?PR\$77_!.[]I_0M;F\=>`M1TW8%O197[[KVQE.V;Y%1AN1EW`%LEHU]:_
M532]1M]8TVWO+26.>UNXUFAEC.5D1AE6![@@@_C7Y6_'W]F[]G7P7\-X]2\&
M_%>]O]0CND26!/)U*66-@1Q"ODD8.TELG`[<U]6_\$JOVA]+^('PDE\"QZS=
M:MJ7@E0L,MU:?99)K%R?*PN]\^6<H3G@;*B7<#ZLHHHJ0/YE/^"LFJ?VQ_P4
MH^-$V<[/$LL&<_\`/-$C_P#9:UO^"-7@P^.?^"G'PBM@NY;+59-2;C.!;VTT
MP/YH*XG_`(**ZG_;/[??QIN0<B3QKJJC_@-RZ_TKM/\`@EO\3T_9\^*WQ`^)
MK2"*X\`>`-6O-/8_Q7]P8;*U7\9;D?@#7],UH361>SI_$Z2BO5Q45^+/YEHS
MA+/O:S^%5')^BE=_@A__``6(_:-_X::_X*%>/]6@N!/I&@70\.:85.5\FTS&
MS+[--YS_`/`ZXW]HWX.#X,?LX_`[[3"8=7\<:1J'BZY#+AA!/=+;VH/L8;8.
M/^NIK@?@=\)M3_:'^-WA7P78/)-JGC#5[?31*3E@9I`'E)_V5+.3Z`U]A_\`
M!PS;V/AC]MCPSX1TI!#I7@GP)I>DV<(/$,:O.57_`+Y*TH.&%Q&$RNCM&+;]
M(QY5][E?Y%3C+%8;%YI67Q227K)\S^Y*WS.W_P"#;37+'X=_%CXU^-M4;R]-
M\*>"1<74G]R(3&9__';<_E7Y[_%/XCW_`,8OB=XC\6ZH[2:CXGU.YU6Y+')W
MSRM(1^&['X5]!_LM_%A?@I_P3C_:-GAD\K5/'][H/@ZS(.&,;_:[BZQ[>1&5
M/_705\O8..%+'LH')/H*TR[!VS+%8QK5N,5Z1BF_Q?X&698R^6X3!QZ*4GZN
M32_!?B??/_!'1K/]E3X.?&K]J+6;2*X7P%I7_".^&8IA\MWJMT4R!]-T"MCG
M;,_I7PYX\\=ZQ\4/&VK>)/$.H7&K:[KMW)?7]Y.VZ2XF=BS,?Q/`Z```<"OT
M%_X*B>"&_8J_X)@?L\_`X;;?6?$$T_B_Q-&HPSW0C!VOZ[9+DH/^O=?2OSDZ
MFLL@Y<3.MF>_M)-1?]R'NJWJTY?,TX@<L-"CE>WLXIR7]^:YG]RLOD?<'_!$
MS_@F7X?_`."@WQ+\5ZAXWEU)?!?@NW@66WLI_(DU"[G+^7&9`,JBI&[-MP22
M@R!FO'/^"GW[.OA7]D_]N+QOX!\%3WDWAW0WM3;K=3>=+;M+:Q3/$7P"P5G(
M!/.,9SUJ#]DS_@I)\7?V(/"VK:-\-M>T_1;'6[L7UZ)M)MKMYI0@0'=*C$`*
M.@XZ^M>7?&+XN:_\>OBAKGC+Q3>C4?$/B.Z:\O[D1+$LLA`'"*`J@````8`%
M:8;!YBLVJXFM47L'&T8IO?35JUK[ZWZV,\5C<M>44L+1IOVZE>4FEMKHG?;;
MIT.S_8+U.\T;]N#X/W.GLRWD?C+2A%M."=UW&I'T*DCZ&OK/_@XS_:NOOBY^
MV-'\.+6[<>&_AI;1JT"-\DVHW$:RRRL.Y2-XXQGI\^/O&O$O^",_PQ?XJ_\`
M!3'X4V:INBTG4GUN8D9"K:0R3`G_`(&J#\:T_P#@MI\$?$/P<_X*-?$&[UJT
MN(['QE>_VYH]VRGRKVWD1`0C="8W#(PZC:.Q&>.NL/4XCI*=N:%)M>KE;\%?
M[SMP[Q%/ARK*%^6=1)^BC?\`%V^X^8?!6C6?B/QIH^G:CJ,.CZ?J%]!;76H3
M*6CL(GD57F8#J$4EB/\`9K]9OVX?^""?@/1_V1=.U[]G[3O$_C;QF+FU\F6#
M68KR#6;5R1+,=Q6(`#Y@8R!VP0:_(:O6/V:/VYOBS^Q_J"R_#SQQK.@VN_S)
M-.\P7&G3GOOMI`T9)]0H/O7;G6`Q]:=.M@*W(X._*[\LO*5M?S.'(\PR^A"I
M1Q]'G4U;F5N:/I?3\CT'_AS=^T]G_DCGB3_P)L__`(]7W9X@_P""/_CWXV?\
M$OO@WX>\8>++?X:R_"FTUS6-8T[4-/-_*K37#RH"8Y@JA(5)P"W^L/TKNO\`
M@EQ_P7R'[4GQ-TGX;?%#1--T'Q7K;>1I.L::66PU*?&1!)$Y+0R-@[2&96;Y
M<*2,_2G_``61^+I^#'_!-CXJ:C'/Y%WJ>E#1+8@X9GO)%MR!_P``D<_@:_.L
MWX@SQX^A@,13C3GSIQ:5[WO&ZNVFK2?2Z/TC*.'\C6`KX[#5)5(.#4DW;:TK
M.R3O=(_FK5Q(H9<[6Y&1CBO5OV)_V5-2_;7_`&F/#?PVTK4(M(N=?,[/?RP&
M>.SCAA>9W9`5+<)MQD<L*\J`"C`Z#@5^E7_!L9\)1XH_:W\:^,)HB\/A+PZ+
M2%^R3W<R@?CY<$@_X%7Z9Q!F$L#EM;%0=G&.GJ]%^+1^7\/9?''9E1PTU>,I
M:^BU?X(^_/\`@E#_`,$M3_P3'TOQW<ZKXNT_Q5>>*GM6-W%8&Q2RM[=93M.Z
M1\Y:1F)R`,"O'_V]/^"B>@_'+4;OP3I46O7/@FTFQ=7FF7\=J=<=3T^>)SY"
ML,CD;R,D8`K[%_;\\*:YXO\`V5O%$.@1K=75K"+N>Q8R!=2MXSNE@)C96^9,
MG`/S%0IR":_*?0_CQX=T=%\[X6_#J_7@CSVU`$_^37]*_FO&XZOC<1+$XE\T
MY6N]%LK=--D?TU@,!0P5".&PT;0CLM]W?KYFEHOB3X*Q8^W^$/B9,>YB\1V8
M7\OLP/ZUU.C>-OV9X'!O?`OQ3;'7.N0N/T9*SM&_:\\&Z85\SX%?"F;''WKD
MD_\`?;M7<^&OV^O!.F;=O[.7P\E]X$!_]"@:N;8["UH/Q0_8[AV_:_`GQ`!Z
M$RWC2#_QVY'\J[#1/C'^Q-D#_A"-65AQFXM+N;^4S5;\,_\`!1SPLNWR/V9[
M;V-C9Q'\L6O]:]$\+_\`!1&SN=@MOV<_'<?_`%YZ.CXZ=/W:U#`\T^,?Q,_9
M(U7X-:W'X=\)2_VL8T-NEEIL]A>%A(APES)&Z1\9R6SD9'4UXC^SG^TMX/\`
MV<?CCH_BK0M`\5V=O`QMK]+G7(;A9+63`D!1;9=VT8<#(^9!S7TQ^V+_`,%!
M+.Y^"/\`9&I?!O7[!-;N8XUMO&&GM::?=+&1(P!CD61G4A2`,#U]_E?X=7\O
M[1_Q!L?#'A+X2_#\:IJ+846ZWXCMD'WI9&-R0L:CDG'H!DD"A+0#]DM*U2WU
MO3+:]M)DN;2[B6:&5#E948`JP/<$$&BO$/!W[$__``C/A'2M-/C/Q+"=/LX;
M;R[2YDCMTV(%Q&I<E4&.`22!CDT5('\X_P"UMJ?]M_M7_%&]SG[7XOU>;_OJ
M]F/]:Y#3/%=[H_AW5=+MY/+M-;\A;L#K(L+F1%^F_#?5%]*M_%'5AK_Q0\37
MX((O]7O+G(.<[YW;^M85?UG0I)480?1+\#^2<35;KSG%[M_B?H=_P;<_LZGX
MH?MIZIXYNH!)IOPWTAY8G9<J+Z[W0Q?B(A<'V(%>9_\`!>CQ,/$O_!4?XA*K
M;DTRWTVQ'MMLH6(_[Z<U^H?_``;V?LX_\*3_`."?NG^(+JW$6K_$F]EUZ4E<
M/]F_U-JI]O+C\P?]=C7X]_\`!5GQ%_PE'_!2+XT76[>$\3SVH/M"J0_^TZ^`
MR;&_7>*<353O&G#D7RDK_C<_0,ZP7U'A;#TGI*I/G?S3M^%CQ%O%UZ?!:Z`)
M"--6_.I&,?QS&)8@Q^B@@?[QKZ'_`."07[+H_:P_;Z\$:)=6WVG0M"G/B+6`
M5RGV>U*NJ-[/,88_HYKYEK]L_P#@V9_9?_X0?X`^*?BK?V^V^\<WW]F::[J<
MBPM20[*?1YRX/_7!:^@XNS)9?E56K#24O=7K+K\E=_(^>X0RUYCFM*G/6,?>
M?I'I\W9?,^5?^#E;QQ+XC_;^TG2&)\GPYX3M(T7MNFFGE8_B-@_X#7YZ2OY<
M;-UVC-?I!_P<P_!74_"7[9/AWQRT$K:'XOT"*RCN-I\M+JU>0/$3T!\N2-@.
MX+>AK\X'7>A&<9K3A&5-Y/A_9[<J^_K^-R.+XSCG.(]I_-^'3\#][O!?[!'[
M.G[*7_!.'0O'OQ-^%7AG7KWPQX0M=5UZZDL$EOKVX:%'=07909&D?8N2!G`R
M*^5Q_P`%&?V`"/\`DV+51_W`K#_Y*KY[_;'_`."TGQ,_;+_9NTKX8ZII6A:!
MHT`M_P"UKC3FE,VMM`%,88,=L:;U5RBYRRCD`8KY1\&^#=6^(OB[3=!T'3;S
M6-;UBX6UL;&UC,D]U*QPJ*HZG/X`<G`%>!E'"V(=.I6S>K-2<F[1J-)1^3MW
M]$?09MQ7156G0RBE!Q44M::;<OFK_P#!/W/_`&!OVH/V29?`OCGXU>#/A;'\
M)-'^'0AT[4]?O=(CCD(NBH\J(6[RLW/E!@!GYU]ZV/VB_P#@I?\`L-?M9^`7
M\-?$'Q=HGB726)>-;G1-1$MHY&/,AE6$/$_^TA!_"O-_VBO^"?&H?LC?\$`?
M%O@2UC6\\40);^)_$SVPWB:<7<$MP%(^\D,,84'NL.[O7XF[O0Y%>-DO#>`S
M:K5QM.M47)-QBU+6R2L[M-ZMMH]G.^)<?E%*E@ZE&F^>"E)..EVW=632T229
M^E^N?\$,O!7[6GP\U'Q[^RK\45\3Z!;7DMF-+\1VTUO^^C5':**Z,:$D!UQO
MCQSR_6OSF\>^!-7^%_CC5_#>OV,NF:YH-Y+87]I*07MIXV*NA()!P0>02#U%
M?5G[!O\`P6=^(/[`7P)UCP'X=\.^&=<L;Z]EU&QN=1,JR:=/*BJYPA`E3*!@
MIP<YYP<#Y1\;>,M4^(WC+5O$.MWDNH:QKEY+J%]=2?>N)Y7+NY[<L3QVK[C)
M:&:4:]6EC)<U)?`W;F:\[6_%7N?"YW7RJM0I5<%'EJOXTK\J]+W_``=CMOV,
M='U#7_VP?A39Z47&HS^+]*%N4^\K"[B.1]`"?PK]:O\`@Z`^+9\/_LT?#_P5
M'*%E\3^(7U&9`>6AM(2/R\RXC/U6OG__`(-W_P#@GQJWQ#^-5O\`''Q'ITUM
MX3\)>8GAXSQE1JVH,IC,T8/6*%6?YNAD*@9V-BG_`,'/7B^ZU/\`;(\#:(^X
M6>D>$1<P@]#)/=S!R/PAC'X5\UCL11QW%.'H4W?V*;?KV^6GXGTV!P];`<*X
MBO45G6:2]._SU/S7K]R/^#8_X3?\(M^QYXN\72)MF\7^)7BC/=H+2)8U_P#(
MCS5^&]?<_P#P1!_:)^+E[^UQ\._A)X<\;:QIO@"ZU6?5]3TF-8GADABB>>9=
MS(719"BJ0K#);U->YQM@:N*RFI"G)12]YWOM'6VE]=$>%P/CJ6%S:G.I%R<O
M=5N\M/N/Z"&0.I!&0>H]:_++]M/P]X[_`&7OVD-3TWPY;6\_A_5_^)GHXC\-
M6=V(HG;#PY\ACF-P5&3G:5/>OU-48&*\!_X*-_`;5?C5^S_<7'AJ>_M_%'AA
MSJ5@+2Y:![E0,30Y##[R<C/\2+7\X)ZG])'P=X9_:=_:`M%46'A^>9>,;/`%
MO@_BEL/YUWWAO]K/]JV)E-KX&O;@=O\`BB7C!_%0M>/^$?#7QSU%(VTKQ!XE
M16`*X\9Q1#'&.#<CVKT?PS\)/VL;M!]B\5>(D7L'\<VS#\OM#5H[`>HZ+^UO
M^UXY4-\)XKD?]-M$E@)_.<8_*NQT3]IW]K"\"^9\$="?U+W/V<_^/3FO-=#^
M!O[9K8:/QE/&B]Y_$%M,,>_RM7'>,_B'^U#%K!\'P^-8O%$VLQ&V_P")'?V$
M[-O!#(LBA9%8`'<R@;1DYXJ;`-^-W[3OQT_:7^,.F>%K3PK'HFH0RMIL>G1Z
M7'>6[3ASYDQGN(F"J`!EE.T*F>:^\OV5/V:+;]GKP-''>SVFL>*KY`VJZM'9
M0VYF;KY48C1<0J?N@\GDGD\8G[$O[)3_`+-'@02:UJU[K_C#58U.IWMQ=23I
M".HMX=Y.(U/4]6(R>,`>WU+8!1112`_-M_\`@V'^"DCEF\:_%(LQR2;VQ))]
M?^/:F2?\&P7P3="/^$T^*0R,<7MCQ_Y+5^D]%?2?ZX9S_P!!$OP_R/FO]3\F
M_P"@>/X_YF1X!\$:?\-/`NC>'=(A^SZ7H-C#IUG%_P`\X8HUC1?P517P?\5O
M^#<OX1?&+XI>)?%VJ^,OB7'J7BC5+G5KI(;NS$223RM(RH#;DA06(&23@#DU
M^@]%>9@<WQF#G*IA:CBY;M=3T\=E&#QD(T\334E'9/H?FRW_``;"?!,J<>-?
MBD#Z_;+'C_R6K[W^`7P5T7]G+X+>&?`OAV*6+1?"NGQ:=:>:0TLBHN#(Y``+
MNV68@#+,>*Z^BM,PSO'XZ*ABZKFEJK]R,OR/`X&3GA*2@WH['!_M%_LS^"?V
MK_AA>^#_`![H5MK^A7I$GE2DI);2@';-%(N&CD7)PRD'DCD$@_G)\3O^#6WP
MIJFJSS^#_BMXAT6T=B8[35=+BU`QCL/-1XB<>ZDU^J]%7EG$&89>G'"57%/I
MHU]S31GF?#^7Y@U+%TE)KKJG]ZLS\D_!W_!K%IT-XC^(?C)J-S;@_/%IN@1P
M.P]GDF<#_ODU]R_L7?\`!+OX/?L)(UWX+\//-XBEC,4VOZK+]KU*1#U57("Q
M*>ZQJH/?-?0]%;9AQ1FF-@Z>)K-Q?162?K9*_P`S++N%\KP,_:8:BE+N[M_)
MMNWR(=0T^#5[">UNH(KFUN8VBFAE0/'*C##*RG@@@D$'@@U^<?[1/_!M-\*/
MBAXHN]5\$>)O$'PZ-Y(TK:?'#'J.G0L23B)'*R(O/"^80.@`'%?I%17'EN<8
MW`2<\'4<&][;/U3T9V9EE&#Q\%#&4U-+:^Z]&M3\@+?_`(-7;C[?B7XUQ_9<
M]4\,?O,?0W.*]Y_9O_X-Q?@C\'=:M]3\6WFO_$N\MF#I;ZFR6NG$CH6@BY?Z
M.[*>X-?H-17JXGC/.:\'3G7=GV2C^*29Y.%X,R;#S]I3H*Z[MO\`!MHJZ)H=
MEX:TJWL-.M+:PL;.-8;>VMXEBA@C485$10`J@<``8%?.?_!07_@EC\./^"BM
MOI5SXK?6-&\0Z%$]O8:SI4J).D+'<89%=622/=\P!&02<$9.?I:BO!PF,KX:
MLJ^'DXS75'OXK!4,31="O!2@^CV/RIF_X-9?"#2YC^+_`(J5,]&T>V9L>F=X
MY_"O?_\`@GM_P1*\%_\`!/[XU2^.]/\`%WB+Q3K+:9-ID*WT$$,%NLK(SR*$
M&[=A-O7HQK[7HKV<5Q9FV)I2H5ZS<9:-62O]R/&PO">4X:K&O1HI2CJG=Z?>
MPI&`92"`01T]:6BOG3Z(_)']N']C"P^"?[1>IP+K?AGP_H'B%VU/25OQ<+LC
M=OWD0\N%P`DA(`SG:4XYK@M*_9L\/7<)D;XP_"NS91G:\U\&_P#285^E/_!1
M[]F:V_:*^`D\RK.-8\*,VJ63V\(FGD15/G0JI90V]!P,CYD6OR_TKPS\/]7B
M@AM_$'C>?4[MTB@MH?#D,AF=N%1<7622<``#FM(O0#3@^!K7&M6NF:)\2_".
MMZA?3+;6MKIMSJ+RW+L<!%46XR2?\3Q7Z-?L`?\`!/[3?V4/#[:SK$=EJ'CS
M4X]MS=1#=%IT9_Y80$@'TW/@%CQT`JC_`,$__P#@GSIG[-ML/%6M;]2\7ZA%
MB'[3"J'1HF7F)55G`E.<.X8_W1QG/U&!BI<NP!1114@%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`$9%?./[/'_``3[\&?"
M#]H+Q?XWA7[==-J3G1[62$+#H:R1I))Y?)W,6D8!B!M7@#J2447`^CJ***`"
*BBB@`HHHH`__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
